Recruiting Lung Cancer Studies in Seattle
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
The purpose of this study is to evaluate the safety, tolerability, drug levels, and preliminary efficacy of BMS-986507 combinations in adult participants with advanced solid tumors....
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
This is Phase 1/2, multicenter, clinical study to evaluate the safety, efficacy, PK, and immunogenicity of IDE849 in subjects with DLL3-expressing tumors including SCLC....
About Lung Cancer Clinical Trials in Seattle
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 2 lung cancer clinical trials recruiting participants in Seattle, WA. These studies are seeking a combined 328 participants. Research is being sponsored by Bristol-Myers Squibb, IDEAYA Biosciences. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in Seattle — FAQ
Are there lung cancer clinical trials in Seattle?
Yes, there are 2 lung cancer clinical trials currently recruiting in Seattle, WA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Seattle?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Seattle research site will contact you about next steps.
Are clinical trials in Seattle free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Seattle studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 2 active trials in Seattle are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov